Public funding and policies for provision of the contraceptive implant, fiscal year 1992.
According to results of a survey of state Medicaid, health and welfare agencies, these agencies spent $61 million in federal and state funds on the provision of the contraceptive implant to low-income women in FY 1992. Some $57 million of this was federal funds, with Medicaid accounting for 84% of all public funds spent on the implant; only nine states committed monies from their own coffers. The Medicaid agencies of 13 states reported restrictions on the number of subsidized implants a woman could receive over her reproductive lifetime. No Medicaid agency has provisions to cover required or requested removals of the device among users who become ineligible for Medicaid while the implant is in place; only eight health departments have policies ensuring subsidized removals for such women.
Kaeser
L
L
Alan Guttmacher Institute (AGI), Washington, D.C.
D003271:Contraceptive Agents, Female / Q000191:economics*; D003363:Cost Control / Q000331:legislation & jurisprudence; D004343:Drug Implants / Q000191:economics; D005193:Family Planning Services / Q000191:economics / Q000331:legislation & jurisprudence; D005260:Female; D005380:Financing, Government / Q000191:economics* / Q000331:legislation & jurisprudence; D005102:Health Expenditures / Q000331:legislation & jurisprudence; D006291:Health Policy / Q000191:economics* / Q000331:legislation & jurisprudence; D006801:Humans; D016912:Levonorgestrel / Q000191:economics*; D008484:Medicaid / Q000191:economics / Q000331:legislation & jurisprudence; D008489:Medical Indigency / Q000191:economics* / Q000331:legislation & jurisprudence; D012946:Social Welfare / Q000191:economics / Q000331:legislation & jurisprudence; D014481:United States
D003271:Contraceptive Agents, Female; D004343:Drug Implants; D016912:Levonorgestrel